Yakob Liawatidewi - 04 Jun 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP Corp Admin Center
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
04 Jun 2022
Net transactions value
-$9,971
Form type
4
Filing time
06 Jun 2022, 16:59:08 UTC
Previous filing
18 Mar 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Tax liability $9,971 -264 -0.43% $37.77 61,735 04 Jun 2022 Direct F1, F2
holding AMPH Common Stock 2,459 04 Jun 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F2 Includes 1,259 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2022.
F3 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.